Joost L Boormans

11PUBLICATIONS
67CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisPredictive and prognostic markersLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 02, 2024
Molecular biomarkers of progression in non-muscle-invasive bladder cancer - beyond conventional risk stratification.

Mitchell Olislagers, Florus C de Jong, Vera C Rutten

|Feb 14, 2024
Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer.

Maud Rijnders, J Alberto Nakauma-González, Debbie G J Robbrecht

|May 24, 2023
Non-muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guérin.

Florus C de Jong, Teemu D Laajala, Robert F Hoedemaeker

|May 15, 2023
Pelvic lymph node dissection for cervical or bladder cancer: embedding residual fat tissue offers no added value.

Jasmijn Vaneman, Heleen J van Beekhuizen, Joost L Boormans

Pageof 2